The pharmaceutical industry is heavily regulated. This regulation results in a high number of recalls in this industry compared to other industries. The pharmaceutical industry is subject to high regulation because of the harmful effects pharmaceuticals can have on consumers. In this paper I examine the valuation effects that a drug recall has on both the recalling firm and the recalling firm's rivals. I perform an event study analysis on the data. I show that there exists a statistically significant negative effect for a drug recall on the recalling firm's market value immediately surrounding the announcement. Additionally, there is a statistically significant positive effect for a drug recall on the recalling firm's rivals after the announcement.